Results 1 - 20 of 10,524 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (9,756)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaThe New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035716 ;PMID: 33616314Full text available |
| 2 |
Material Type: Article
|
|
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR -Mutant Lung CancerClinical cancer research, 2020-06, Vol.26 (11), p.2654-2663 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-3563 ;PMID: 31911548Full text available |
| 3 |
Material Type: Article
|
|
Kinase drug discovery 20 years after imatinib: progress and future directionsNature reviews. Drug discovery, 2021-07, Vol.20 (7), p.551-569 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00195-4 ;PMID: 34002056Full text available |
| 4 |
Material Type: Article
|
|
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyJournal of thoracic oncology, 2018-03, Vol.13 (3), p.323-358 [Peer Reviewed Journal]Copyright © 2018 by the International Association for the Study of Lung Cancer ;Copyright © 2018 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2017.12.001 ;PMID: 29396253Full text available |
| 5 |
Material Type: Article
|
|
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesThe New England journal of medicine, 2019-10, Vol.381 (18), p.1718-1727 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1908681 ;PMID: 31566307Full text available |
| 6 |
Material Type: Article
|
|
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX studyAnnals of oncology, 2020-08, Vol.31 (8), p.1056-1064 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.04.478 ;PMID: 32418886Full text available |
| 7 |
Material Type: Article
|
|
Advances in covalent drug discoveryNature reviews. Drug discovery, 2022-12, Vol.21 (12), p.881-898 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;Springer Nature Limited 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-022-00542-z ;PMID: 36008483Full text available |
| 8 |
Material Type: Article
|
|
Exon 14 Deleted MET Receptor as a New Biomarker and Target in CancersJNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5) [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw262 ;PMID: 28376232Full text available |
| 9 |
Material Type: Article
|
|
Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid TumorsCancer discovery, 2019-04, Vol.9 (4), p.482-4912019 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-18-1175 ;PMID: 30867161Full text available |
| 10 |
Material Type: Article
|
|
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeCell, 2018-11, Vol.175 (4), p.984-997.e24 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.09.006 ;PMID: 30388455Full text available |
| 11 |
Material Type: Article
|
|
Response and Resistance to BCR-ABL1-Targeted TherapiesCancer cell, 2020-04, Vol.37 (4), p.530-542 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2020.03.006 ;PMID: 32289275Full text available |
| 12 |
Material Type: Article
|
|
Kinase inhibition in autoimmunity and inflammationNature reviews. Drug discovery, 2021-01, Vol.20 (1), p.39-63 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-020-0082-8 ;PMID: 33077936Full text available |
| 13 |
Material Type: Article
|
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateAnnals of the rheumatic diseases, 2017-06, Vol.76 (6), p.960-977 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-210715 ;PMID: 28264816 ;CODEN: ARDIAOFull text available |
| 14 |
Material Type: Article
|
|
Kinase-targeted cancer therapies: progress, challenges and future directionsMolecular cancer, 2018-02, Vol.17 (1), p.48-48, Article 48 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-018-0804-2 ;PMID: 29455673Full text available |
| 15 |
Material Type: Article
|
|
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung CancerCancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.689-698 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-18-1281 ;PMID: 30718357Full text available |
| 16 |
Material Type: Article
|
|
Moving treatment-free remission into mainstream clinical practice in CMLBlood, 2016-07, Vol.128 (1), p.17-23 [Peer Reviewed Journal]2016 American Society of Hematology ;2016 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-01-694265 ;PMID: 27013442Full text available |
| 17 |
Material Type: Article
|
|
Kinase inhibitors: the road aheadNature reviews. Drug discovery, 2018-05, Vol.17 (5), p.353-377 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group May 2018 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2018.21 ;PMID: 29545548Full text available |
| 18 |
Material Type: Article
|
|
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L TrialJournal of thoracic oncology, 2021-12, Vol.16 (12), p.2091-2108 [Peer Reviewed Journal]2021 International Association for the Study of Lung Cancer ;Copyright © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2021.07.035 ;PMID: 34537440Full text available |
| 19 |
Material Type: Article
|
|
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer ModelsCancer discovery, 2018-10, Vol.8 (10), p.1237-12492018 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-18-0444 ;PMID: 30045908Full text available |
| 20 |
Material Type: Article
|
|
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR -Mutant Lung CancersClinical cancer research, 2019-02, Vol.25 (3), p.1063-1069 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-18-1102 ;PMID: 30045933Full text available |
Results 1 - 20 of 10,524 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (9,756)
Refine My Results
Creation Date
- Before 2007 (372)
- 2007 To 2010 (1,483)
- 2011 To 2014 (2,668)
- 2015 To 2019 (3,522)
- After 2019 (2,482)
-
More options
New Records
- New From Last Month (29)
- New From Last 3 Month (125)
-
More options
Resource Type
- Articles (10,513)
- Conference Proceedings (5)
- Web Resources (2)
- Thesises (postgraduate) (2)
- Books (1)
- Book Chapters (1)
-
More options
Subject
- Protein Kinase Inhibitors - Therapeutic Use (10,515)
- Humans (10,098)
- Science & Technology (9,456)
- Life Sciences & Biomedicine (9,022)
- Oncology (5,210)
- Female (4,226)
- Antineoplastic Agents - Therapeutic Use (3,796)
- Male (3,738)
- Protein Kinase Inhibitors - Pharmacology (3,298)
- Middle Aged (2,950)
- Mutation (2,930)
- Aged (2,579)
- Animals (2,546)
- Lung Neoplasms - Drug Therapy (2,545)
- Adult (2,241)
- Treatment Outcome (2,213)
- Carcinoma, Non-Small-Cell Lung - Drug Therapy (1,986)
- Kinases (1,836)
- Lung Neoplasms - Genetics (1,733)
- Tumors (1,607)
-
More options
Databases
- MEDLINE (10,515)
- ProQuest Central (5,440)
- Geneva Foundation Free Medical Journals at publisher websites (4,708)
- PubMed Central (3,953)
- DOAJ Directory of Open Access Journals (3,134)
- ROAD: Directory of Open Access Scholarly Resources (2,470)
- HighWire Press (Free Journals) (2,105)
- Springer Nature OA Free Journals (859)
- Nature出版集团开放获取期刊 (664)
- Wiley-Blackwell Open Access Collection (647)
- Free E- Journals (302)
- ProQuest One Psychology (280)
- IngentaConnect Open Access Journals (251)
- Journals@Ovid Open Access Journal Collection Rolling (232)
- PLoS_OA刊 (202)
- Freely Accessible Japanese Titles (ERDB Project) (188)
- Taylor & Francis Open Access (170)
- OUP_牛津大学出版社OA刊 (139)
- SWEPUB Freely available online (93)
- Wolters Kluwer Open Health (92)
-
More options
Language
Journal Title
- Blood (294)
- Bmc Cancer (159)
- Clinical Cancer Research (400)
- Future Oncology (176)
- International Journal Of Molecular Sciences (201)
- Journal Of Clinical Oncology (276)
- Journal Of Thoracic Oncology (332)
- Leukemia (164)
- Oncotarget (177)
- Plos One (190)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||